XML 97 R79.htm IDEA: XBRL DOCUMENT v3.22.4
Derivative Instruments and Hedging Activities - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Nov. 07, 2022
Sep. 30, 2016
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Derivative [Line Items]              
Revenues other than USD     47.00%        
Teva other comprehensive loss     $ 493.0        
Derivative, Loss, Statement of Income or Comprehensive Income [Extensible Enumeration]     Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest        
Forward starting interest rate swaps and treasury lock agreements losses     $ 30.0 $ 37.0 $ 31.0    
Interest Rate Swap Gain     4.0 5.0 3.0    
Deferred purchase asset     270.0 235.0      
Sold receivables     636.0 685.0 734.0    
Cash received on settlement of position     3.0        
Derivative, Gain on Derivative     $ 11.0 31.0      
Derivative, Gain, Statement of Income or Comprehensive Income [Extensible Enumeration]     Revenue from Contract with Customer, Excluding Assessed Tax        
Net Revenues [Member] | Not Designated as Hedging Instrument, Economic Hedge [Member]              
Derivative [Line Items]              
Gain (Loss) on Derivative Instruments, Net, Pretax     $ (11.0) [1] $ (31.0) [1] $ 0.5    
Senior Notes Due 2023 Two [Member]              
Derivative [Line Items]              
Notional amount hedge debt   $ 3,000.0         $ 500.0
Previously hedge debt rate             2.80%
Cash received on settlement of position             $ 10.0
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)   41.0          
Senior Notes Due 2022 [Member]              
Derivative [Line Items]              
Notional amount hedge debt   $ 844.0          
Previously hedge debt rate   2.95%          
Senior Notes Due 2021 [Member]              
Derivative [Line Items]              
Notional amount hedge debt   $ 450.0       $ 588.0  
Previously hedge debt rate   3.65%          
Cash received on settlement of position           $ 95.0  
Senior Notes Due 2020 [Member]              
Derivative [Line Items]              
Cash received on settlement of position     500.0        
Senior Notes Due 2021 Two [Member]              
Derivative [Line Items]              
Previously hedge debt rate           3.65%  
Accounts Receivable Securitization Facility [Member] | PNC Bank [Member]              
Derivative [Line Items]              
Sold receivables     436.0        
Derivative notional amount $ 1.0            
Derivatives term of contract 3 years            
Transfer of financial assets sold and derecognized     $ 820.0        
Accounts Receivable Securitization Facility [Member] | PNC Bank [Member] | November 2025 [Member]              
Derivative [Line Items]              
Derivative notional amount decrease $ 500.0            
Accounts Receivable Securitization Facility [Member] | PNC Bank [Member] | November 2023 [Member]              
Derivative [Line Items]              
Derivative notional amount $ 1,000.0            
[1] Teva entered into option and forward contracts designed to limit the exposure of foreign exchange fluctuations on projected revenues and expenses recorded in euro, Swiss franc, Japanese yen, British pound, Canadian dollar, Polish zloty and some other currencies to protect its projected operating results for 2022 and 2023. These derivative instruments do not meet the criteria for hedge accounting, however, they are accounted for as an economic hedge. These derivative instruments, which may include hedging transactions against future projected revenues and expenses, are recognized on the balance sheet at their fair value on a quarterly basis, while the foreign exchange impact on the underlying revenues and expenses may occur in subsequent quarters. In 2022, the positive impact from these derivatives recognized under revenues was $11 million. In 2021, the positive impact from these derivatives recognized under revenues was $31 million. Changes in the fair value of the derivative instruments are recognized in the same line item in the statements of income as the underlying exposure being hedged. The cash flows associated with these derivatives are reflected as cash flows from operating activities in the consolidated statements of cash flows.